Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients (Q78807364)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12532159%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

title

Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12532159%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference

3

L J Mandarino

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12532159%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

Y Miyazaki

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12532159%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

R Pipek

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12532159%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

Ralph A DeFronzo

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12532159%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

publication date

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12532159%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12532159%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12532159%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

88-94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12532159%20AND%20SRC:MED&resulttype=core&format=json

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

16 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Medical hazards of obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Tumor necrosis factor alpha: a key component of the obesity-diabetes link

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Tumor necrosis factor alpha inhibits signaling from the insulin receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Relation between plasma tumor necrosis factor-alpha and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Influences of glucose loading and of injected insulin on hepatic glucose output

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

1 reference

7 January 2021

Role of fatty acids in the pathogenesis of insulin resistance and NIDDM.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Relationship between serum tumor necrosis factor-alpha and insulin resistance in obese men with Type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Monokine regulation of glucose transporter mRNA in L6 myotubes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Tumor necrosis factor: function, release and clearance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Relationship between circulating leptin and peripheral fat distribution in obese subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Leptin selectively decreases visceral adiposity and enhances insulin action.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Leptin secretion from subcutaneous and visceral adipose tissue in women.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

The expression of TNF alpha by human muscle. Relationship to insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Insulin up-regulates tumor necrosis factor-alpha production in macrophages through an extracellular-regulated kinase-dependent pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0802187

7 January 2021

Identifiers

DOI

10.1038/SJ.IJO.0802187

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12532159%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference